X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
influenza (182) 182
humans (149) 149
index medicus (122) 122
viruses (102) 102
influenza, human - virology (89) 89
antiviral agents - pharmacology (74) 74
animals (65) 65
infectious diseases (65) 65
influenza, human - epidemiology (65) 65
oseltamivir (62) 62
virology (62) 62
drug resistance, viral (60) 60
public health (54) 54
influenza viruses (52) 52
influenza vaccines (50) 50
microbiology (50) 50
surveillance (50) 50
female (49) 49
influenza a virus, h1n1 subtype - genetics (49) 49
influenza a virus, h1n1 subtype - isolation & purification (49) 49
antiviral agents (48) 48
zanamivir (48) 48
influenza a virus, h1n1 subtype - drug effects (47) 47
neuraminidase - antagonists & inhibitors (47) 47
neuraminidase - genetics (47) 47
adult (46) 46
influenza, human - drug therapy (46) 46
adolescent (44) 44
immunology (44) 44
united states - epidemiology (43) 43
virus diseases (42) 42
middle aged (41) 41
infant (40) 40
child (39) 39
child, preschool (39) 39
male (39) 39
infections (38) 38
influenza a virus, h3n2 subtype - isolation & purification (37) 37
population surveillance (37) 37
influenza b virus - isolation & purification (36) 36
aged (35) 35
influenza a virus (35) 35
oseltamivir - pharmacology (35) 35
pharmacology & pharmacy (35) 35
seasons (35) 35
infection (33) 33
young adult (33) 33
influenza a virus, h3n2 subtype - genetics (32) 32
influenza b virus - drug effects (31) 31
influenza b virus - genetics (30) 30
antiviral agents - therapeutic use (29) 29
cell line (29) 29
pandemics (29) 29
vaccines (29) 29
hemagglutinin (28) 28
influenza a virus, h3n2 subtype - drug effects (28) 28
public, environmental & occupational health (28) 28
drug resistance (26) 26
epidemics (26) 26
influenza, human - prevention & control (26) 26
mutation (26) 26
neuraminidase - metabolism (26) 26
orthomyxoviridae (26) 26
analysis (25) 25
dogs (25) 25
health aspects (25) 25
neuraminidase inhibitors (25) 25
enzyme inhibitors - pharmacology (24) 24
swine influenza (24) 24
mortality (23) 23
resistance (23) 23
susceptibility (23) 23
antivirals (22) 22
influenza, human - mortality (22) 22
medicine (22) 22
avian influenza (21) 21
drug resistance, viral - genetics (21) 21
research (21) 21
a virus (20) 20
a viruses (20) 20
hemagglutinin glycoproteins, influenza virus - genetics (20) 20
oseltamivir - therapeutic use (20) 20
hospitalization - statistics & numerical data (19) 19
influenza a virus - drug effects (19) 19
mice (19) 19
phylogeny (19) 19
united-states (19) 19
vaccination (19) 19
viral proteins - genetics (19) 19
diseases (18) 18
pneumonia - mortality (18) 18
transmission (18) 18
prevention (17) 17
abridged index medicus (16) 16
active-site (16) 16
article (16) 16
influenza a virus - genetics (16) 16
microbial sensitivity tests (16) 16
molecular sequence data (16) 16
neuraminidase (16) 16
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 2/2001, Volume 183, Issue 4, pp. 523 - 531
Journal Article
The Journal of infectious diseases, ISSN 0022-1899, 07/2019
Journal Article
Virus Research, ISSN 0168-1702, 2004, Volume 103, Issue 1, pp. 199 - 203
A wide use of inhibitors of influenza virus neuraminidase (NAIs) to control influenza in humans demands a better understanding of the mechanisms involved in... 
Neuraminidase inhibitor | Drug resistance | Immunocompromised patients | HEMAGGLUTININ | ACTIVE-SITE | IN-VITRO SELECTION | 4-GUANIDINO-NEU5AC2EN | OSELTAMIVIR | A VIRUS | neuraminidase inhibitor | VIROLOGY | HOST-CELL | immunocompromised patients | drug resistance | HIGHLY POTENT | RECEPTOR SPECIFICITY | BINDING
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 11/1998, Volume 178, Issue 5, pp. 1257 - 1262
Zanamivir, a neuraminidase inhibitor, has shown promise as a drug to control influenza. During prolonged treatment with zanamivir, a mutant virus was isolated... 
Cercopithecine herpesvirus 1 | Receptors | Antivirals | Viruses | Orthomyxoviridae | Infections | Cell membranes | Genetic mutation | Sequence analysis | Virology | INFECTIOUS DISEASES | ASSAY | EFFICACY | ACTIVE-SITE | INHIBITOR 4-GUANIDINO-NEU5AC2EN | MICROBIOLOGY | IMMUNOLOGY | NEURAMINIDASE | AFFINITY | A VIRUSES | GENERATION | RECEPTOR SPECIFICITY | BINDING | Humans | Cercopithecus aethiops | Neuraminidase - genetics | Infant | Influenza, Human - complications | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - therapy | Drug Resistance, Microbial - genetics | Receptors, Virus - genetics | Zanamivir | Hemagglutination Inhibition Tests | Bone Marrow Transplantation - immunology | Influenza B virus - genetics | Immunosuppression - adverse effects | Female | Influenza B virus - immunology | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - complications | Receptors, Virus - drug effects | Influenza, Human - drug therapy | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - immunology | Vero Cells | Orthomyxoviridae Infections - drug therapy | Cell Line | Enzyme-Linked Immunosorbent Assay | Antiviral Agents - therapeutic use | Sialic Acids - therapeutic use | RNA, Viral - analysis | Guanidines | Ferrets | Enzyme Inhibitors - therapeutic use | Animals | Dogs | Neuraminidase - antagonists & inhibitors | Mutation | Amino Acid Substitution | Pyrans
Journal Article
Journal Article
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2014, Volume 14, Issue 2, pp. 109 - 118
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2009, Volume 360, Issue 25, pp. 2616 - 2625
Journal Article